Azelastine

Links shared publicly online about this topic

Meda Receives FDA Approval of New Astepro (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine

drugs.com — “Astepro (azelastine) is used to treat rhinitis symptoms. Includes Astepro side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 4, 2009 at 12:11 am By:

drugscom Drugs.com Health Site

Meda Receives FDA Approval of Astepro (azelastine) Nasal Spray 0.15% Once-Daily Nasal Antihistamine - http://bit.ly/10rcwI

2 years ago...

A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic Rhinitis

content.karger.com — “A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic RhinitisView full resource at content.karger.com

  • View Related
  • Share

Most Recently Shared on August 23, 2011 at 2:28 pm By:

JuanCIvancevich Juan C. Ivancevich, MD Allergist, Physician, Doctor, and Internist

Azelastine and Levocabastine are effective and safe in the treatment of moderate-to-severe persistent allergic rhinitis http://t.co/idxc6cI

6 months ago...

Astelin and Glaucoma: Is this nasal spray safe for patients with glaucoma?

intelihealth.com — “Astelin and Glaucoma: Is this nasal spray safe for patients with glaucoma?View full resource at intelihealth.com

  • View Related
  • Share

Most Recently Shared on April 4, 2010 at 6:58 pm By:

SusanS_Health Susan Scroggins Health Advocate and Active Health Library

Astelin and Glaucoma: Is this nasal spray safe for patients with glaucoma? http://bit.ly/997rHn

2 years ago...

Meda: Positive Study Results Presented For Dymista

medicalnewstoday.com — “Meda (STO:MEDAA) announced positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patieView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 23, 2011 at 12:05 pm By:

Meda: Dymista filed with the FDA | Business Wire

businesswire.com — “Regulatory News A New Drug Application for a novel formulation of azelastine hydrochloride and fluticasone propionate, tentatively named “DymistView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on April 4, 2011 at 12:59 pm By:

wheezemd Michael Blaiss, MD Doctor, Allergist, and Physician

Dymista (combination of fluticasone propionate/azelastine) filed with the FDA for seasonal allergic rhinitis by Meda - http://goo.gl/600KE

10 months ago...

Meda: Positive Study Results Presented For Dymista

medicalnewstoday.com — “Meda (STO:MEDAA) announced positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patieView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 23, 2011 at 4:47 pm By:

Ear_Nose_Throat Ear, Nose, and Throat OW Health

Meda: Positive Study Results Presented For Dymista: Meda (STO:MEDAA) announced positive results from a Phase III... http://bit.ly/dLca5L

11 months ago...

Allergy/Immunology Article | Rhinitis, Vasomotor

mdlinx.com — “Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 30, 2011 at 3:54 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride... http://bit.ly/e5FB5p #Allergy

10 months ago...

Otolaryngology Article | Rhinitis

mdlinx.com — “A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic RhinitisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 15, 2011 at 6:58 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocab... http://t.co/jbxNckJ #ENT

6 months ago...

Allergy/Immunology Article | Rhinitis

mdlinx.com — “A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Levocabastine Nasal Spray 0.05% in Patients with Moderate-to-Severe Allergic RhinitisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 16, 2011 at 9:11 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

A Multicenter Randomized Double-Blind 2-Week Comparison Study of Azelastine Nasal Spray 0.1% versus Lev... http://t.co/TtIhWSj #Allergy

6 months ago...

Meda Pharma introduces 5ml nasal spray Rhinolast Allergy - Pharmaceutical Business Review

pharmaceutical-business-review.com — “Meda Pharmaceuticals has introduced 5ml nasal spray Rhinolast Allergy as an over-the-counter therapy to help children from the age of five tackle theiView full resource at pharmaceutical-business-review.com

  • View Related
  • Share

Most Recently Shared on May 4, 2011 at 9:26 am By:

_gluten_free Allergydiet Health Business

Meda Pharma introduces 5ml nasal spray Rhinolast Allergy http://bit.ly/jodOaD

9 months ago...

Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - ONA

oncologynurseadvisor.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitisView full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on March 22, 2011 at 6:07 pm By:

Phase 3 Study of Dymista for Seasonal Allergic Rhinitis - MPR

empr.com — “Meda announced positive results from its Phase 3 trial of Dymista (azelastine HCl and fluticasone propionate) nasal spray in patients with seasonal allergic rhinitisView full resource at empr.com

  • View Related
  • Share

Most Recently Shared on March 22, 2011 at 6:08 pm By:

eMPR MPR Medical Publisher

MPR News: Phase 3 Study of Dymista for Seasonal Allergic Rhinitis: Meda announced positive results from its Phas... http://bit.ly/hpduGL

11 months ago...

Phase 3 Results for Dymista for Allergic Rhinitis - ONA

oncologynurseadvisor.com — “Meda announced new results from its Phase 3 study of Dymista (azelastine HCl and fluticasone propionate; Meda) nasal spray for the treatment of allergic rhinitis.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 15, 2011 at 3:03 pm By:

FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon | #epharma #in | World of DTC Marketing.com

worldofdtcmarketing.com — “FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon | #epharma #in | World of DTC Marketing.comView full resource at worldofdtcmarketing.com

  • View Related
  • Share

Most Recently Shared on February 8, 2010 at 5:46 pm By:

richmeyer Rich Meyer Health Executive

FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon http://goo.gl/fb/FEYv #epharmain

2 years ago...

Astepro nasal spray 0.15% approved for nasal allergy symptoms - MPR

empr.com — “The FDA has approved Astepro (azelastine HCl nasal spray, from Meda) 0.15%, a nasal antihistamine, for the relief of symptoms associated with seasonal and perennial allergic rhinitis in patients 12 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on September 2, 2009 at 4:38 pm By:

eMPR MPR Medical Publisher

MPR News: Astepro nasal spray 0.15% approved for nasal allergy symptoms: The FDA has approved Astepro (.. http://bit.ly/L02N5

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related WisdomCards

Featuring the top 3 experts for this topic

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • JuanCIvancevich

    Juan C. Ivancevich, MD

    Allergist - Head Allergy & Immunology, Santa Isabel Clinic, Buenos Aires. Assistant Professor of Immunology, Medicine School, Universidad del Salvador, Buenos Aires. Member of the Board of Directors, World Allergy Organization. President of the South Cone Chapter on the Latin American Society of Allergy, Asthma & Immunology.

    View Profile

  • SusanS_Health

    Susan Scroggins

    Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390